Code Sepsis

Rapid Methods To Diagnose Sepsis and Detect Hematopathogens. Part I: The Impact and Attributes of Sepsis

Donna Wolk, Albert B. Fiorello

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Bloodstream infections are among the top causes of death in the United States, and substantial mortality is attributed to testing delays in determinating the microbial cause(s) and selection of the appropriate antibiotic. In this review, we summarize the human and financial impact of sepsis, as well as the predisposing factors, symptoms, and common modes of bacterial pathogenesis. We also detail important clinical and laboratory criteria for the diagnosis of sepsis and key aspects of the Surviving Sepsis Campaign Guidelines as they relate to diagnosis, therapy, and resuscitation from the septic event. Clinical laboratories must expand their understanding of the complexities related to diagnosing and treating sepsis in order to expand their role as productive members of interdisciplinary health care teams focused on improving survival from sepsis and limiting the financial impact that sepsis imposes on our health care systems.

Original languageEnglish (US)
Pages (from-to)33-37
Number of pages5
JournalClinical Microbiology Newsletter
Volume32
Issue number5
DOIs
StatePublished - Mar 1 2010

Fingerprint

Sepsis
Patient Care Team
Clinical Laboratory Techniques
Resuscitation
Causality
Cause of Death
Guidelines
Anti-Bacterial Agents
Delivery of Health Care
Survival
Mortality
Infection
Therapeutics

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Code Sepsis : Rapid Methods To Diagnose Sepsis and Detect Hematopathogens. Part I: The Impact and Attributes of Sepsis. / Wolk, Donna; Fiorello, Albert B.

In: Clinical Microbiology Newsletter, Vol. 32, No. 5, 01.03.2010, p. 33-37.

Research output: Contribution to journalArticle

@article{9c53ce7888a24d96853551f0919851b0,
title = "Code Sepsis: Rapid Methods To Diagnose Sepsis and Detect Hematopathogens. Part I: The Impact and Attributes of Sepsis",
abstract = "Bloodstream infections are among the top causes of death in the United States, and substantial mortality is attributed to testing delays in determinating the microbial cause(s) and selection of the appropriate antibiotic. In this review, we summarize the human and financial impact of sepsis, as well as the predisposing factors, symptoms, and common modes of bacterial pathogenesis. We also detail important clinical and laboratory criteria for the diagnosis of sepsis and key aspects of the Surviving Sepsis Campaign Guidelines as they relate to diagnosis, therapy, and resuscitation from the septic event. Clinical laboratories must expand their understanding of the complexities related to diagnosing and treating sepsis in order to expand their role as productive members of interdisciplinary health care teams focused on improving survival from sepsis and limiting the financial impact that sepsis imposes on our health care systems.",
author = "Donna Wolk and Fiorello, {Albert B.}",
year = "2010",
month = "3",
day = "1",
doi = "10.1016/j.clinmicnews.2010.02.001",
language = "English (US)",
volume = "32",
pages = "33--37",
journal = "Clinical Microbiology Newsletter",
issn = "0196-4399",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Code Sepsis

T2 - Rapid Methods To Diagnose Sepsis and Detect Hematopathogens. Part I: The Impact and Attributes of Sepsis

AU - Wolk, Donna

AU - Fiorello, Albert B.

PY - 2010/3/1

Y1 - 2010/3/1

N2 - Bloodstream infections are among the top causes of death in the United States, and substantial mortality is attributed to testing delays in determinating the microbial cause(s) and selection of the appropriate antibiotic. In this review, we summarize the human and financial impact of sepsis, as well as the predisposing factors, symptoms, and common modes of bacterial pathogenesis. We also detail important clinical and laboratory criteria for the diagnosis of sepsis and key aspects of the Surviving Sepsis Campaign Guidelines as they relate to diagnosis, therapy, and resuscitation from the septic event. Clinical laboratories must expand their understanding of the complexities related to diagnosing and treating sepsis in order to expand their role as productive members of interdisciplinary health care teams focused on improving survival from sepsis and limiting the financial impact that sepsis imposes on our health care systems.

AB - Bloodstream infections are among the top causes of death in the United States, and substantial mortality is attributed to testing delays in determinating the microbial cause(s) and selection of the appropriate antibiotic. In this review, we summarize the human and financial impact of sepsis, as well as the predisposing factors, symptoms, and common modes of bacterial pathogenesis. We also detail important clinical and laboratory criteria for the diagnosis of sepsis and key aspects of the Surviving Sepsis Campaign Guidelines as they relate to diagnosis, therapy, and resuscitation from the septic event. Clinical laboratories must expand their understanding of the complexities related to diagnosing and treating sepsis in order to expand their role as productive members of interdisciplinary health care teams focused on improving survival from sepsis and limiting the financial impact that sepsis imposes on our health care systems.

UR - http://www.scopus.com/inward/record.url?scp=76449085342&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76449085342&partnerID=8YFLogxK

U2 - 10.1016/j.clinmicnews.2010.02.001

DO - 10.1016/j.clinmicnews.2010.02.001

M3 - Article

VL - 32

SP - 33

EP - 37

JO - Clinical Microbiology Newsletter

JF - Clinical Microbiology Newsletter

SN - 0196-4399

IS - 5

ER -